Registry of Cutting Balloon and DCB Intervention in Femoropopliteal Stenosis/Occlusion.
- Conditions
- Femoropoliteal Stenosis/OcclusionPeripheral Artery DiseaseCutting-balloonDrug-coated-balloon
- Interventions
- Device: Cutting-Balloon-PTA (VascuTrak) and Drug Coated Ballon PTA
- Registration Number
- NCT02198105
- Lead Sponsor
- Caritasklinik St. Theresia
- Brief Summary
Observational registry including patients with peripheral artery disease due to femoro-popliteal stenosis or occlusion treated with cutting ballon- and subsequent drug-coated-ballon-percutaneous-transluminal-angioplasty (PTA).
- Detailed Description
The registry includes consecutive patients with symptomatic peripheral artery disease due to femoro-popliteal stenosis or occlusion treated with cutting ballon- and subsequent drug-coated-ballon-percutaneous-transluminal-angioplasty (PTA).
Interventional procedure:
1. PTA with Cutting-Balloon (60-120 seconds).
2. PTA with Drug-Coated-Balloon (60 seconds).
Technical success is defined as
1. no recoil \>30%
2. no dissection \>Type B
3. no stenting \>30% of lesion length.
Follow-up of patients after 6 months and 12 months (ABI, Rutherford-classification, MACE, TLR, TVR, Binary Restenosis).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- peripheral artery disease (PAD) with femoro-popliteal stenosis >70% or occlusion (vessel diameter 4-6mm)
- age 18-99
- informed consent
- proximal / iliacal stenosis
- stenosis/occlusion of all arteries below the knee
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Femoropopliteal stenosis Cutting-Balloon-PTA (VascuTrak) and Drug Coated Ballon PTA Consecutive patients with symptomatic peripheral artery disease due to femoro-popliteal stenosis/occlusion. Intervention with Cutting-Balloon-PTA (VascuTrak) and Drug Coated Ballon-PTA.
- Primary Outcome Measures
Name Time Method Clinically driven target lesion revascularization (TLR) 6 months clinically driven target lesion revascularization
- Secondary Outcome Measures
Name Time Method Binary restenosis 12 months clinically driven target vessel revascularization (TVR) 12 months Change in Ankle Brachial Index (ABI) 12 months Change in Rutherford-classification 12 months Amputation 12 months major cardiac adverse events 12 months myocardial infarction, stroke, death, cardiovascular death
Clinically driven target lesion revascularization (TLR) 12 months
Trial Locations
- Locations (1)
CaritasKlinikum, St. Theresia
🇩🇪Saarbrücken, Saarland, Germany